Systemic immune-inflammation index may be used to predict the development of colorectal cancer from colonic polyps
Key Points
To evaluate the effectiveness of the systemic immune-inflammation index as a biomarker for colorectal cancer risk in patients with colonic polyps.
Assessment of systemic immune-inflammation index in patients with colonic polyps
Analysis of its correlation with colorectal cancer risk
Systemic immune-inflammation index serves as a noninvasive biomarker for colorectal cancer risk
Higher index values are associated with increased risk of developing colorectal cancer.
Abstract
SII is a promising, noninvasive biomarker for identifying patients at increased risk of CRC among those with colonic polyps. Further prospective studies are needed to confirm these findings.
Like
Bookmark
Share
Like
Bookmark
Share
Systemic immune-inflammation index may be used to predict the development of colorectal cancer from colonic polyps | Synapse